Scientific Advisory Board

      Prof. Elias Arnér, M.D. Ph.D.

      Preclinical R&D Advisor

      Prof. Arnér is a professor in biochemistry, focusing on redox biology and cancer research at the Department of medical biochemistry and biophysics (MBB), Karolinska Institute in Stockholm, Sweden. In addition to being considered a world authority of redox enzymology Prof. Arnér is also highly involved in education. He received his Ph.D. in medicine and medical degree from the Karolinska Institute, and a post-doctoral degree from Ludwig Maximilian University of München, Germany. He has also been an invited lecturer and chair in several conferences, and serves as an editorial board member of prominent journals such as JBC and BBA.

      Prof. Rolf Karlsten, M.D.

      Clinical Pain Advisor

      Prof. Karlsten is currently the Head of the Multidisciplinary Pain Centre and Rehabilitation Medicine at Uppsala University Hospital, Sweden. He has a broad experience in pain research and management, medical in-licensing, R&D and projects in clinical development. Previously, he has held positions such as Medical Science Director at AstraZeneca, Senior Consultant at Uppsala University Hospital, and has worked with KOL networks in Europe, the U.S. and Japan. His background of studies includes M.D. and a Ph.D. in Medical Science from Uppsala University, Sweden, and a diploma in Pharmaceutical Medicine from the Karolinska Institute in Stockholm, Sweden.

      Alexander Moscho, Ph.D.

      Business Development Advisor

      Dr. Moscho is currently the Chief Operating Officer (COO) and Member of the Executive Committee at GHD GesundHeits GmbH in PlatsAhrensburg, Germany. Previously, he has held positions such as Chief Strategy Officer (CSO) and EVP at UCB Pharma S.A., Chief Executive Officer (CEO) at Bayer UK & Ireland, Head of Corporate Development at Bayer AG and Associate Principal at McKinsey & Company in Munich, Germany.